International journal of radiation oncology, biology, physics 87: S3.Videtic GM, Hu C, Singh A, et al. Radiation Therapy Oncology Group (RTOG) protocol 0915: A randomized phase 2 study comparing 2 stereo- tactic body radiation therapy (SBRT) schedules for medically inoperable patients with ...
The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancerOver the past 2 decades, the Radiation Therapy Oncology Group (RTOG) has played a significant role in clarifying the role of radiation therapy (RT) in the treatment of nonsmall cell lung cancer (...
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202. Deregulation of the retinoblastoma (RB) pathway is commonly found in virtually all known human tumors. p16, the upstream regulator of RB, is among the most... A Chakrava...
Over the past 2 decades, the Radiation Therapy Oncology Group (RTOG) has played a significant role in clarifying the role of radiation therapy (RT) in the treatment of nonsmall cell lung cancer (NSCLC). RTOG lung cancer research has evol... None - 《Lung Cancer》 被引量: 95发表: 1995...
Between March 21, 2002, and May 3, 2004, Radiation Therapy Oncology Group (RTOG) 0211 enrolled 31 and 147 GBM patients in the phase 1 and 2 arms, respectively. Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy (RT) and continued post...
Patients who choose to be part of a cancer clinical trial can be assured that patient safety and radiation therapy protocol compliance is stringently monitored under the TROG Cancer ResearchRadiation Therapy Quality Assurance (RTQA) program.
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standar... Purpose: The optimal fractionation schedule for radiotherapy of head and neck cancer has been controversial. The objective of this randomized ...
Two major strategies, acting synergistically, will enable further widening of the therapeutic window of radiation oncology in the era of precision medicine: technology-driven improvement of treatment conformity, including advanced image guidance and particle therapy, and novel biological concepts for ...
Acceptable compliance with protocol treatment; Systemic therapy delivery.SauseWilliam T.ScottCharlesJNCI: Journal of the National Cancer InstituteSause WT,Scott C,Taylor S,et al.Radiation Therapy Oncology Group(RTOG) 88-08 and Eastern Cooperative Onclogy Group(ECOG)4588: preliminary results of a ...
To report secondary efficacy endpoints of Radiation Therapy Oncology Group protocol 0247, primary endpoint analysis of which demonstrated that preoperative radiation therapy (RT) with capecitabine plus oxaliplatin achieved a pathologic complete remission prespecified threshold (21%) to merit further study, ...